Global Epilepsy Drugs Market Size study & Forecast, by Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), by Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Regional Analysis, 2023-2030
Global Epilepsy Drugs Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2023-2030. Epilepsy is a neurological disorder characterized by recurrent seizures, and there are many drugs available to treat this condition. The choice of medication depends on the type of epilepsy, the age of the patient, and other factors such as the patient's overall health and the presence of other medical conditions. However, the market for epileptic drugs is growing as a result of an increase in the number of persons who suffer from epilepsy. A widespread neurological illness, epilepsy is a major market-driving factor due to the rise in prevalence of the condition globally. Additionally, epilepsy is affecting more people due to factors like population growth, ageing populations, and improved diagnosis, all of which contribute to the market's expansion. For instance, epilepsy incidence rates rise with age and are highest in people over the age of 75, according to a report released by UpToDate Inc. in August 2021. As a result, the demand for epilepsy drugs is driven by the rising prevalence of epilepsy among the senior population, which is supporting market growth.
Moreover, the rise in new drug approvals by the government authority is anticipated to create a lucrative demand for the market during forecast period. For instance, In March 2022, The United States Food and Drug Administration granted Lupin's abbreviated new drug application (ANDA) for Vigabatrin approval. It is an anti-epileptic drug that will be sold as a 500 mg oral solution USP. Also, In March 2022, The US Food and Drug Administration approved the drug Ztalmy from Marinus Pharmaceuticals to treat seizures in people with CDKL5 deficiency, a genetic form of epilepsy. As a result, the rising drug approvals are anticipated to support the market growth during projected period. Additionally, rising research and development activities related to epilepsy drugs is anticipated to create a lucrative opportunity for the market during forecast period. However, the side effects associated with the drugs stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Epilepsy Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising burden of epilepsy coupled with the strategic initiatives, awareness campaigns, and development of new products by the market players in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing prevalence of epilepsy, and the presence of high unmet medical needs in emerging economies of India and China.
Major market players included in this report are:
Novartis AG
GlaxoSmithKline plc
Sanofi S.Aa
UCB S.A.
Abbott Laboratories
Bausch Health Companies, Inc
Viatris Inc.
Johnson & Johnson
Sumitomo Pharma Co., Ltd
H. Lundbeck A/S
Recent Developments in the Market:
In Nov. 2020, According to UCB S.A., a global pharmaceutical company, the U.S. Food and Drug Administration (FDA) has approved both VIMPAT (lacosamide) CV and VIMPAT injection for intravenous use in children four years of age and older for the treatment of primary generalised tonic-clonic seizures (PGTCS).
Global Epilepsy Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Drugs, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drugs:
First Generation Anti-epileptics
Second Generation Anti-epileptics
Third Generation Anti-epileptics
By Distribution Channel:
Hospital Pharmacy
Pharmacy Stores
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Moreover, the rise in new drug approvals by the government authority is anticipated to create a lucrative demand for the market during forecast period. For instance, In March 2022, The United States Food and Drug Administration granted Lupin's abbreviated new drug application (ANDA) for Vigabatrin approval. It is an anti-epileptic drug that will be sold as a 500 mg oral solution USP. Also, In March 2022, The US Food and Drug Administration approved the drug Ztalmy from Marinus Pharmaceuticals to treat seizures in people with CDKL5 deficiency, a genetic form of epilepsy. As a result, the rising drug approvals are anticipated to support the market growth during projected period. Additionally, rising research and development activities related to epilepsy drugs is anticipated to create a lucrative opportunity for the market during forecast period. However, the side effects associated with the drugs stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Epilepsy Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, rising burden of epilepsy coupled with the strategic initiatives, awareness campaigns, and development of new products by the market players in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing prevalence of epilepsy, and the presence of high unmet medical needs in emerging economies of India and China.
Major market players included in this report are:
Novartis AG
GlaxoSmithKline plc
Sanofi S.Aa
UCB S.A.
Abbott Laboratories
Bausch Health Companies, Inc
Viatris Inc.
Johnson & Johnson
Sumitomo Pharma Co., Ltd
H. Lundbeck A/S
Recent Developments in the Market:
In Nov. 2020, According to UCB S.A., a global pharmaceutical company, the U.S. Food and Drug Administration (FDA) has approved both VIMPAT (lacosamide) CV and VIMPAT injection for intravenous use in children four years of age and older for the treatment of primary generalised tonic-clonic seizures (PGTCS).
Global Epilepsy Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Drugs, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drugs:
First Generation Anti-epileptics
Second Generation Anti-epileptics
Third Generation Anti-epileptics
By Distribution Channel:
Hospital Pharmacy
Pharmacy Stores
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Epilepsy Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Epilepsy Drugs Market, by Drugs, 2020-2030 (USD Billion)
1.2.3. Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL EPILEPSY DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL EPILEPSY DRUGS MARKET DYNAMICS
3.1. Epilepsy Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in the New Drug Approvals over the Past Few Years
3.1.1.2. Growing Prevalence of Epilepsy
3.1.2. Market Challenges
3.1.2.1. Side Effects Associated with the Drugs
3.1.3. Market Opportunities
3.1.3.1. Rising Research and Development Activities Related to Epilepsy Drugs
CHAPTER 4. GLOBAL EPILEPSY DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL EPILEPSY DRUGS MARKET, BY DRUGS
5.1. Market Snapshot
5.2. Global Epilepsy Drugs Market by Drugs, Performance - Potential Analysis
5.3. Global Epilepsy Drugs Market Estimates & Forecasts by Drugs 2020-2030 (USD Billion)
5.4. Epilepsy Drugs Market, Sub Segment Analysis
5.4.1. First Generation Anti-epileptics
5.4.2. Second Generation Anti-epileptics
5.4.3. Third Generation Anti-epileptics
CHAPTER 6. GLOBAL EPILEPSY DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Epilepsy Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Epilepsy Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Epilepsy Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacy
6.4.2. Pharmacy Stores
6.4.3. Others
CHAPTER 7. GLOBAL EPILEPSY DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Epilepsy Drugs Market, Regional Market Snapshot
7.4. North America Epilepsy Drugs Market
7.4.1. U.S. Epilepsy Drugs Market
7.4.1.1. Drugs breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Epilepsy Drugs Market
7.5. Europe Epilepsy Drugs Market Snapshot
7.5.1. U.K. Epilepsy Drugs Market
7.5.2. Germany Epilepsy Drugs Market
7.5.3. France Epilepsy Drugs Market
7.5.4. Spain Epilepsy Drugs Market
7.5.5. Italy Epilepsy Drugs Market
7.5.6. Rest of Europe Epilepsy Drugs Market
7.6. Asia-Pacific Epilepsy Drugs Market Snapshot
7.6.1. China Epilepsy Drugs Market
7.6.2. India Epilepsy Drugs Market
7.6.3. Japan Epilepsy Drugs Market
7.6.4. Australia Epilepsy Drugs Market
7.6.5. South Korea Epilepsy Drugs Market
7.6.6. Rest of Asia Pacific Epilepsy Drugs Market
7.7. Latin America Epilepsy Drugs Market Snapshot
7.7.1. Brazil Epilepsy Drugs Market
7.7.2. Mexico Epilepsy Drugs Market
7.8. Middle East & Africa Epilepsy Drugs Market
7.8.1. Saudi Arabia Epilepsy Drugs Market
7.8.2. South Africa Epilepsy Drugs Market
7.8.3. Rest of Middle East & Africa Epilepsy Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. GlaxoSmithKline plc
8.3.3. Sanofi S.Aa
8.3.4. UCB S.A.
8.3.5. Abbott Laboratories
8.3.6. Bausch Health Companies, Inc
8.3.7. Viatris Inc.
8.3.8. Johnson & Johnson
8.3.9. Sumitomo Pharma Co., Ltd
8.3.10. H. Lundbeck A/S.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Epilepsy Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Epilepsy Drugs Market, by Drugs, 2020-2030 (USD Billion)
1.2.3. Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL EPILEPSY DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL EPILEPSY DRUGS MARKET DYNAMICS
3.1. Epilepsy Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in the New Drug Approvals over the Past Few Years
3.1.1.2. Growing Prevalence of Epilepsy
3.1.2. Market Challenges
3.1.2.1. Side Effects Associated with the Drugs
3.1.3. Market Opportunities
3.1.3.1. Rising Research and Development Activities Related to Epilepsy Drugs
CHAPTER 4. GLOBAL EPILEPSY DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL EPILEPSY DRUGS MARKET, BY DRUGS
5.1. Market Snapshot
5.2. Global Epilepsy Drugs Market by Drugs, Performance - Potential Analysis
5.3. Global Epilepsy Drugs Market Estimates & Forecasts by Drugs 2020-2030 (USD Billion)
5.4. Epilepsy Drugs Market, Sub Segment Analysis
5.4.1. First Generation Anti-epileptics
5.4.2. Second Generation Anti-epileptics
5.4.3. Third Generation Anti-epileptics
CHAPTER 6. GLOBAL EPILEPSY DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Epilepsy Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Epilepsy Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Epilepsy Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacy
6.4.2. Pharmacy Stores
6.4.3. Others
CHAPTER 7. GLOBAL EPILEPSY DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Epilepsy Drugs Market, Regional Market Snapshot
7.4. North America Epilepsy Drugs Market
7.4.1. U.S. Epilepsy Drugs Market
7.4.1.1. Drugs breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Epilepsy Drugs Market
7.5. Europe Epilepsy Drugs Market Snapshot
7.5.1. U.K. Epilepsy Drugs Market
7.5.2. Germany Epilepsy Drugs Market
7.5.3. France Epilepsy Drugs Market
7.5.4. Spain Epilepsy Drugs Market
7.5.5. Italy Epilepsy Drugs Market
7.5.6. Rest of Europe Epilepsy Drugs Market
7.6. Asia-Pacific Epilepsy Drugs Market Snapshot
7.6.1. China Epilepsy Drugs Market
7.6.2. India Epilepsy Drugs Market
7.6.3. Japan Epilepsy Drugs Market
7.6.4. Australia Epilepsy Drugs Market
7.6.5. South Korea Epilepsy Drugs Market
7.6.6. Rest of Asia Pacific Epilepsy Drugs Market
7.7. Latin America Epilepsy Drugs Market Snapshot
7.7.1. Brazil Epilepsy Drugs Market
7.7.2. Mexico Epilepsy Drugs Market
7.8. Middle East & Africa Epilepsy Drugs Market
7.8.1. Saudi Arabia Epilepsy Drugs Market
7.8.2. South Africa Epilepsy Drugs Market
7.8.3. Rest of Middle East & Africa Epilepsy Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. GlaxoSmithKline plc
8.3.3. Sanofi S.Aa
8.3.4. UCB S.A.
8.3.5. Abbott Laboratories
8.3.6. Bausch Health Companies, Inc
8.3.7. Viatris Inc.
8.3.8. Johnson & Johnson
8.3.9. Sumitomo Pharma Co., Ltd
8.3.10. H. Lundbeck A/S.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Epilepsy Drugs Market, report scope
TABLE 2. Global Epilepsy Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Epilepsy Drugs Market estimates & forecasts by Drugs 2020-2030 (USD Billion)
TABLE 4. Global Epilepsy Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Epilepsy Drugs Market
TABLE 70. List of primary sources, used in the study of global Epilepsy Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Epilepsy Drugs Market, report scope
TABLE 2. Global Epilepsy Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Epilepsy Drugs Market estimates & forecasts by Drugs 2020-2030 (USD Billion)
TABLE 4. Global Epilepsy Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Epilepsy Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Epilepsy Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Epilepsy Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Epilepsy Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Epilepsy Drugs Market
TABLE 70. List of primary sources, used in the study of global Epilepsy Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Epilepsy Drugs Market, research methodology
FIG 2. Global Epilepsy Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Epilepsy Drugs Market, key trends 2022
FIG 5. Global Epilepsy Drugs Market, growth prospects 2023-2030
FIG 6. Global Epilepsy Drugs Market, porters 5 force model
FIG 7. Global Epilepsy Drugs Market, pest analysis
FIG 8. Global Epilepsy Drugs Market, value chain analysis
FIG 9. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Epilepsy Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Epilepsy Drugs Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Epilepsy Drugs Market, research methodology
FIG 2. Global Epilepsy Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Epilepsy Drugs Market, key trends 2022
FIG 5. Global Epilepsy Drugs Market, growth prospects 2023-2030
FIG 6. Global Epilepsy Drugs Market, porters 5 force model
FIG 7. Global Epilepsy Drugs Market, pest analysis
FIG 8. Global Epilepsy Drugs Market, value chain analysis
FIG 9. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Epilepsy Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Epilepsy Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia Pacific Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Epilepsy Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Epilepsy Drugs Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
